⟵ Back to Search Results
BGB-3111-302

Completed

A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström’s Macroglobulinemia (WM)

Beigene Study ID info

BGB-3111-302

ClinicalTrials.gov ID info

NCT03053440

EudraCT Number info

2016-002980-33

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan